Investing.com - Cognex (NASDAQ: CGNX) reported third quarter EPS of $0.20, $0.02 better than the analyst estimate of $0.18. Revenue for the quarter came in at $235M versus the consensus estimate of $233.84M.
Guidance
Cognex sees Q4 2024 revenue of $210.00M-$230.00M versus the analyst consensus of $220.80M.
Cognex's stock price closed at $40.45. It is up 5.83% in the last 3 months and up 12.39% in the last 12 months.
Cognex saw 0 positive EPS revisions and 14 negative EPS revisions in the last 90 days. See Cognex's stock price’s past reactions to earnings here.
According to InvestingPro, Cognex's Financial Health score is "fair performance".
Check out Cognex's recent earnings performance, and Cognex's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar